Navigation Links
Ubiquitous engineered nanomaterials cause lung inflammation, study finds
Date:5/6/2013

(SACRAMENTO, Calif.) -- A consortium of scientists from across the country has found that breathing ultrafine particles from a large family of materials that increasingly are found in a host of household and commercial products, from sunscreens to the ink in copy machines to super-strong but lightweight sporting equipment, can cause lung inflammation and damage.

The research on two of the most common types of engineered nanomaterials is published online today in Environmental Health Perspectives, the journal of the National Institute of Environmental Health Sciences (NIEHS). It is the first multi-institutional study examining the health effects of engineering nanomaterials to replicate and compare findings from different labs across the country.

The study is critical, the researchers said, because of the large quantities of nanomaterials being used in industry, electronics and medicine. Earlier studies had found when nanomaterials are taken into the lungs they can cause inflammation and fibrosis. The unique contribution of the current study is that all members of the consortium were able to show similar findings when similiar concentrations of the materials were introduced into the respiratory system. The findings should provide guidance for creating policy for the safe development of nanotechnology.

"This research provides further confirmation that nanomaterials have the potential to cause inflammation and injury to the lungs. Although small amounts of these materials in the lungs do not appear to produce injury, we still must remain vigilant in using care in the diverse applications of these materials in consumer products and foods," said Kent Pinkerton, a study senior author and the director of the UC Davis Center for Health and the Environment."

Used for their ability to confer strength and flexibility because of their tubular and spherical structures, the ubiquitous and highly malleable materials may be composed of everything from carbon to gold. The current study examined the health effects of inhaling two types of nanomaterials, those made from forms of titanium dioxide and those made from multi-walled carbon nanotubes, a substance with a tensile strength 100 times stronger than steel.

The study was conducted as part of the NIEHS NanoGo Consortium, which includes researchers at North Carolina State University, UC Davis, East Carolina University, the Health Effects Laboratory of the National Institute for Occupational Safety and Health, the University of Rochester, the University of Washington and the Center for Environmental Implications of Nanotechnology.

The primary concern for exposure to nanomaterials is by inhalation, although dermal, eye and ingestion exposures also may occur during the manufacture and commercial application of these materials in a wide variety of products. The researchers examined responses of the lungs to nanomaterials made from three forms of titanium dioxide and three forms of multi-walled carbon nanotubes in a mouse model.


'/>"/>

Contact: Phyllis Brown
phyllis.brown@ucdmc.ucdavis.edu
916-734-9023
University of California - Davis Health System
Source:Eurekalert

Related medicine news :

1. Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
2. Lab-engineered muscle implants restore function in animals
3. Genetically-engineered preclinical models predict pharmacodynamic response
4. Hardwoods4less Introduces New Line of Engineered Hardwood Flooring
5. Immune cells engineered in lab to resist HIV infection, Stanford study shows
6. Selexis SA Announces Publication in Metabolic Engineering of Data Demonstrating Improvement of Therapeutic Protein Secretion with Engineered CHO Cells
7. Almost Nuts! Supports Whole Foods Decision on Banning Gentically Modified Salmon and Continues to Support the Movement Against Genetically Engineered Foods
8. Engineered T cells kill tumors but spare normal tissue in an animal model
9. Repairing articular cartilage defects with an injectable gel engineered with gene modified BMSCs
10. A TECNALIA study reveals the loss of nanomaterials in surface treatments caused by water
11. New Electro-Blowing Needleless Multi-Jet – More Efficient Nanofibre Production Can Expand the Applicability of Nanomaterials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... , ... CareSet Labs released the Root NPI Graph today at the 2017 ... improved version of the Doctor Referral teaming dataset commonly available from Medicare. , Originally ... the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released by ...
(Date:6/25/2017)... ... June 25, 2017 , ... June is Men’s Health Month and the focus is ... among men in the U.S. and the third most common cause of cancer related death ... man in seven will be diagnosed with prostate cancer during his lifetime. Those at ...
(Date:6/24/2017)... ... June 24, 2017 , ... The Pennsylvania Athletic Trainers’ Society’s ... and Erie Convention Center on June 8-10. The weekend consisted of many ... award and scholarship presentations, and professional networking. , On Friday June 9th, ...
(Date:6/24/2017)... , ... June 24, 2017 , ... The weather is ... time outdoors. Home and business owners should be aware that the summer months provide ... In fact, mechanical locks and keys can be negatively affected from direct exposure to ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... today announced the launch of Care Management Alerts and Dashboards, an innovative new ... throughout Rhode Island. , RIQI’s Care Management Alerts and Dashboards provide near real-time ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... Calif. , June 14, 2017 The ... the City of Fremont and ... of the bio-pharma industry in California ... technology, enabling executive networking, and fostering workforce development. The ... development and growth of start-ups, as well as small ...
(Date:6/13/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... Food and Drug Administration (FDA) has notified the Company that ... Zhejiang, China manufacturing facility has been ... clearance of the Warning Letter related to our ... of the progress we have made in our ongoing quality ...
(Date:6/11/2017)... and Company (NYSE: LLY ) announced today ... an investigational treatment for the prevention of episodic and ... endpoints for galcanezumab compared to placebo at both studied ... REGAIN) will be presented today at the American Headache ... . "The detailed Phase 3 ...
Breaking Medicine Technology: